Vontobel Holding’s AngioDynamics ANGO Stock Holding History

Vontobel Holding’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,641	Closed	-$85.1K	–	1107
2023 Q3	$85.1K	Hold	11,641	–	–	﹤0.01%	1026
2023 Q2	$121K	Buy	+11,641	New	+$112K	﹤0.01%	1039

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vontobel Holding's ANGO Position: Q4 2023 in Review

Vontobel Holding sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 11,641 shares — an estimated $85.1K sold.

Vontobel Holding first reported a position in ANGO in Q2 2023 and held it in 2 quarters. The position peaked at $121K in Q2 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

Vontobel Holding reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
Vontobel Holding sold 11,641 AngioDynamics shares in Q4 2023, an estimated $85.1K.
Vontobel Holding first reported a position in AngioDynamics in Q2 2023 and held it in 2 quarters.
Vontobel Holding's AngioDynamics position peaked at $121K in Q2 2023.
150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.